BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 31769670)

  • 1. Proline-Based Allosteric Inhibitors of Zika and Dengue Virus NS2B/NS3 Proteases.
    Millies B; von Hammerstein F; Gellert A; Hammerschmidt S; Barthels F; Göppel U; Immerheiser M; Elgner F; Jung N; Basic M; Kersten C; Kiefer W; Bodem J; Hildt E; Windbergs M; Hellmich UA; Schirmeister T
    J Med Chem; 2019 Dec; 62(24):11359-11382. PubMed ID: 31769670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploiting the unique features of Zika and Dengue proteases for inhibitor design.
    Majerová T; Novotný P; Krýsová E; Konvalinka J
    Biochimie; 2019 Nov; 166():132-141. PubMed ID: 31077760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Inhibition of NS2B/NS3 Protease: A New Therapeutic Opportunity to Treat Dengue and Zika Virus Infection.
    Starvaggi J; Previti S; Zappalà M; Ettari R
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery and SAR studies of methionine-proline anilides as dengue virus NS2B-NS3 protease inhibitors.
    Zhou GC; Weng Z; Shao X; Liu F; Nie X; Liu J; Wang D; Wang C; Guo K
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6549-54. PubMed ID: 24268549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery, X-ray Crystallography and Antiviral Activity of Allosteric Inhibitors of Flavivirus NS2B-NS3 Protease.
    Yao Y; Huo T; Lin YL; Nie S; Wu F; Hua Y; Wu J; Kneubehl AR; Vogt MB; Rico-Hesse R; Song Y
    J Am Chem Soc; 2019 May; 141(17):6832-6836. PubMed ID: 31017399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allosteric inhibition of the NS2B-NS3 protease from dengue virus.
    Yildiz M; Ghosh S; Bell JA; Sherman W; Hardy JA
    ACS Chem Biol; 2013 Dec; 8(12):2744-52. PubMed ID: 24164286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the Zika virus two-component NS2B-NS3 protease and structure-assisted identification of allosteric small-molecule antagonists.
    Shiryaev SA; Farhy C; Pinto A; Huang CT; Simonetti N; Elong Ngono A; Dewing A; Shresta S; Pinkerton AB; Cieplak P; Strongin AY; Terskikh AV
    Antiviral Res; 2017 Jul; 143():218-229. PubMed ID: 28461069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-guided Discovery of a Novel Non-peptide Inhibitor of Dengue Virus NS2B-NS3 Protease.
    Li L; Basavannacharya C; Chan KW; Shang L; Vasudevan SG; Yin Z
    Chem Biol Drug Des; 2015 Sep; 86(3):255-64. PubMed ID: 25533891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure activity relationship (SAR) and quantitative structure activity relationship (QSAR) studies showed plant flavonoids as potential inhibitors of dengue NS2B-NS3 protease.
    Sarwar MW; Riaz A; Dilshad SMR; Al-Qahtani A; Nawaz-Ul-Rehman MS; Mubin M
    BMC Struct Biol; 2018 Apr; 18(1):6. PubMed ID: 29673347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SAR evolution towards potent C-terminal carboxamide peptide inhibitors of Zika virus NS2B-NS3 protease.
    Colarusso S; Ferrigno F; Ponzi S; Pavone F; Conte I; Abate L; Beghetto E; Missineo A; Amaudrut J; Bresciani A; Paonessa G; Tomei L; Montalbetti C; Bianchi E; Toniatti C; Ontoria JM
    Bioorg Med Chem; 2022 Mar; 57():116631. PubMed ID: 35123179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SAR of novel benzothiazoles targeting an allosteric pocket of DENV and ZIKV NS2B/NS3 proteases.
    Maus H; Barthels F; Hammerschmidt SJ; Kopp K; Millies B; Gellert A; Ruggieri A; Schirmeister T
    Bioorg Med Chem; 2021 Oct; 47():116392. PubMed ID: 34509861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NS2B-NS3 protease inhibitors as promising compounds in the development of antivirals against Zika virus: A systematic review.
    Nunes DAF; Santos FRDS; da Fonseca STD; de Lima WG; Nizer WSDC; Ferreira JMS; de Magalhães JC
    J Med Virol; 2022 Feb; 94(2):442-453. PubMed ID: 34636434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of novel and potential inhibitors against the dengue virus NS2B/NS3 protease using virtual screening and biomolecular simulations.
    Nasir A; Samad A; Ajmal A; Li P; Islam M; Ullah S; Shah M; Bai Q
    Int J Biol Macromol; 2024 Jun; 272(Pt 1):132855. PubMed ID: 38834129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of antiviral molecules for dengue: In silico search and biological evaluation.
    Cabarcas-Montalvo M; Maldonado-Rojas W; Montes-Grajales D; Bertel-Sevilla A; Wagner-Döbler I; Sztajer H; Reck M; Flechas-Alarcon M; Ocazionez R; Olivero-Verbel J
    Eur J Med Chem; 2016 Mar; 110():87-97. PubMed ID: 26807547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flavonoids as noncompetitive inhibitors of Dengue virus NS2B-NS3 protease: inhibition kinetics and docking studies.
    de Sousa LR; Wu H; Nebo L; Fernandes JB; da Silva MF; Kiefer W; Kanitz M; Bodem J; Diederich WE; Schirmeister T; Vieira PC
    Bioorg Med Chem; 2015 Feb; 23(3):466-70. PubMed ID: 25564380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dengue Virus NS2B/NS3 Protease Inhibitors Exploiting the Prime Side.
    Lin KH; Ali A; Rusere L; Soumana DI; Kurt Yilmaz N; Schiffer CA
    J Virol; 2017 May; 91(10):. PubMed ID: 28298600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, Structure-Activity Relationships, and Antiviral Activity of Allosteric Inhibitors of Flavivirus NS2B-NS3 Protease.
    Nie S; Yao Y; Wu F; Wu X; Zhao J; Hua Y; Wu J; Huo T; Lin YL; Kneubehl AR; Vogt MB; Ferreon J; Rico-Hesse R; Song Y
    J Med Chem; 2021 Mar; 64(5):2777-2800. PubMed ID: 33596380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-active carbazole derivatives as inhibitors of the zika virus protease.
    Rassias G; Zogali V; Swarbrick CMD; Ki Chan KW; Chan SA; Gwee CP; Wang S; Kaplanai E; Canko A; Kiousis D; Lescar J; Luo D; Matsoukas MT; Vasudevan SG
    Eur J Med Chem; 2019 Oct; 180():536-545. PubMed ID: 31344613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Antiviral Peptide from
    Ji M; Zhu T; Xing M; Luan N; Mwangi J; Yan X; Mo G; Rong M; Li B; Lai R; Jin L
    Toxins (Basel); 2019 Oct; 11(10):. PubMed ID: 31658707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zika virus NS2B/NS3 proteinase: A new target for an old drug - Suramin a lead compound for NS2B/NS3 proteinase inhibition.
    Coronado MA; Eberle RJ; Bleffert N; Feuerstein S; Olivier DS; de Moraes FR; Willbold D; Arni RK
    Antiviral Res; 2018 Dec; 160():118-125. PubMed ID: 30393012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.